Cargando…

Antioxidant Biomolecules and Their Potential for the Treatment of Difficult-to-Treat Depression and Conventional Treatment-Resistant Depression

Major depression is a devastating disease affecting an increasing number of people from a young age worldwide, a situation that is expected to be worsened by the COVID-19 pandemic. New approaches for the treatment of this disease are urgently needed since available treatments are not effective for a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riveros, María Eugenia, Ávila, Alba, Schruers, Koen, Ezquer, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944633/ https://www.ncbi.nlm.nih.gov/pubmed/35326190 http://dx.doi.org/10.3390/antiox11030540

Ejemplares similares

#TreatmentResistantDepression: A qualitative content analysis of Tweets about difficult‐to‐treat depression
por: Talbot, Amelia, et al.
Publicado: (2023)

Viewpoint: Difficult-to-treat depression versus treatment-resistant depression: A new integrative perspective for managing depression
por: Paganin, Walter
Publicado: (2023)

Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
por: Berríos-Cárcamo, Pablo, et al.
Publicado: (2020)

Clinical research challenges posed by difficult-to-treat depression
por: Rush, A. John, et al.
Publicado: (2022)

Difficult-To-Treat Depression. Scoping Review
por: Paganin, Walter, et al.
Publicado: (2023)

A model for the management of difficult to treat depression
por: Mcallister-Williams, H.
Publicado: (2021)

Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)
por: Kavakbasi, E., et al.
Publicado: (2023)

Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea
por: Kim, Namwoo, et al.
Publicado: (2019)

Anxiety and depression in small fiber neuropathy
por: Damci, Aysun, et al.
Publicado: (2022)

Is cognitive dysfunction involved in difficult-to-treat depression? Characterizing resistance from a cognitive perspective
por: López-Solà, Clara, et al.
Publicado: (2020)

The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review
por: Demyttenaere, Koen, et al.
Publicado: (2018)

25(OH)D levels are decreased in patients with difficult-to-treat depression
por: Grudet, C., et al.
Publicado: (2022)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

The ‘difficult-to-treat depression’ and the ‘response paradigm’ models: Implications and relevance to patient management
por: McAllister-Williams, RH, et al.
Publicado: (2021)

Treatment resistant depression in women with peripartum depression
por: Cepeda, M. Soledad, et al.
Publicado: (2019)

Natural Antioxidants: Fascinating or Mythical Biomolecules?
por: Ndhlala, Ashwell R., et al.
Publicado: (2010)

Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life
por: Sackeim, Harold A., et al.
Publicado: (2023)

Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026
por: Chapman, Natalya, et al.
Publicado: (2022)

Is treatment resistant depression a different subtype of depression?
por: Fiorillo, A.
Publicado: (2021)

Rethinking treatment-resistant depression to quasi-tenacious depression
por: Arjmand, Shokouh, et al.
Publicado: (2023)

The Potential Use of Ebselen in Treatment-Resistant Depression
por: Ramli, Fitri Fareez, et al.
Publicado: (2022)

Could ketamine be the answer to treating treatment-resistant major depressive disorder?
por: Ramadan, Abdullah Mohammed, et al.
Publicado: (2020)

Neuromodulation for treatment-resistant depression
por: Holtzheimer, Paul E., et al.
Publicado: (2012)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
por: Lubrano, Ennio, et al.
Publicado: (2023)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

Pharmacological Treatments for Patients with Treatment-Resistant Depression
por: Ruberto, Valerie L., et al.
Publicado: (2020)

Treatment-Resistant Depression in Poland—Epidemiology and Treatment
por: Gałecki, Piotr, et al.
Publicado: (2022)

New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
por: Felgueiras, Helena P.
Publicado: (2022)

High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation
por: Sani, S, et al.
Publicado: (2017)

Non-pharmacological treatment in difficult-to-treat rheumatoid arthritis
por: Majnik, Judit, et al.
Publicado: (2022)

CORRIGENDUM TO: Neuromodulation for treatment-resistant depression
por: Holtzheimer, Paul E., et al.
Publicado: (2012)

Neuromodulation therapies and treatment-resistant depression
por: Al-Harbi, Khalid Saad, et al.
Publicado: (2012)

Update on Neuromodulation for Treatment-Resistant Depression
por: Bewernick, Bettina, et al.
Publicado: (2015)

Editorial for Treatment-Resistant Depression (TRD)
por: Kasper, Siegfried, et al.
Publicado: (2019)

Cushing's Syndrome and Treatment-Resistant Depression
por: Shukla, Lekhansh
Publicado: (2017)

Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019)

Esketamine/ketamine for treatment-resistant depression
por: Lacerda, Acioly L.T.
Publicado: (2020)

Excess deaths in treatment-resistant depression
por: Brenner, Philip, et al.
Publicado: (2021)

Esketamine hydrochloride for treatment-resistant depression
Publicado: (2021)

Suicidality in Treatment-Resistant Depression Patients
por: Lyubov, E. B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jncl95kqcfljg8dci12tg1ang4